HIF-1α Pathway Orchestration by LCN2: A Key Player in Hypoxia-Mediated Colitis Exacerbation.

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Inflammatory bowel disease (IBD) pathogenesis involves complex inflammatory pathways.
• Hypoxia is increasingly recognized as a contributing factor in chronic inflammatory conditions.
• The HIF-1α signaling pathway plays a critical role in cellular responses to low oxygen environments.

Purpose of the Study:

• To investigate the role of hypoxia in exacerbating inflammatory bowel disease (IBD).
• To elucidate the involvement of the HIF-1α signaling pathway and lipocalin 2 (LCN2) in hypoxia-driven colitis.
• To explore the impact of hypoxia on macrophage polarization and inflammatory responses.

Main Methods:

• Murine model of dextran sulfate sodium (DSS)-induced colitis under hypoxic conditions.
• Transcriptome sequencing and bioinformatics analysis to identify key genes and pathways.
• In vitro studies using RAW264.7 cells and LCN2 knockout cells.
• In vivo validation using LCN2-silencing lentivirus and HIF-1α pathway activator (DMOG).

Main Results:

• Hypoxia significantly exacerbates DSS-induced colitis in mice.
• Lipocalin 2 (LCN2) was identified as a key mediator of hypoxia-induced inflammation.
• Hypoxia promotes M1 macrophage polarization and activates the HIF-1α and glycolysis pathways.
• LCN2 silencing and HIF-1α pathway modulation reversed hypoxia-induced inflammatory responses.

Conclusions:

• Hypoxia exacerbates colitis by upregulating LCN2 and activating the HIF-1α signaling pathway.
• LCN2 mediates hypoxia-induced inflammation and M1 macrophage polarization via glycolysis.
• Targeting the hypoxia-LCN2-HIF-1α axis presents a potential therapeutic strategy for IBD.